Filing Details
- Accession Number:
- 0001179110-10-015907
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-12 12:10:23
- Reporting Period:
- 2010-11-09
- Filing Date:
- 2010-11-12
- Accepted Time:
- 2010-11-12 12:10:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1198229 | Paul Berg | Beckman Center, Rm. B062 Stanford University School Of Medicine Stanford CA 94305 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-09 | 40,000 | $11.59 | 72,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-09 | 40,000 | $38.52 | 32,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-11-09 | 40,000 | $0.00 | 40,000 | $11.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,000 | 2013-04-29 | No | 4 | M | Direct |
Footnotes
- Options vested in full after one year on April 29, 2004.
- Sale prices reported for the transactiion reported here range from $38.34 to $38.80. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.
Billionaire Hedge Funds
